JP2024540303A5 - - Google Patents
Info
- Publication number
- JP2024540303A5 JP2024540303A5 JP2024526614A JP2024526614A JP2024540303A5 JP 2024540303 A5 JP2024540303 A5 JP 2024540303A5 JP 2024526614 A JP2024526614 A JP 2024526614A JP 2024526614 A JP2024526614 A JP 2024526614A JP 2024540303 A5 JP2024540303 A5 JP 2024540303A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- solid
- formula
- solvate
- iii
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163263474P | 2021-11-03 | 2021-11-03 | |
| CN2021128533 | 2021-11-03 | ||
| US63/263,474 | 2021-11-03 | ||
| CNPCT/CN2021/128533 | 2021-11-03 | ||
| PCT/US2022/079221 WO2023081757A1 (en) | 2021-11-03 | 2022-11-03 | Pi3k-alpha inhibitors and methods of making and using the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024540303A JP2024540303A (ja) | 2024-10-31 |
| JP2024540303A5 true JP2024540303A5 (enExample) | 2025-11-06 |
Family
ID=86242193
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024526614A Pending JP2024540303A (ja) | 2021-11-03 | 2022-11-03 | Ｐｉ３ｋ－アルファ阻害剤、その調製方法及び使用方法 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20260125374A1 (enExample) |
| EP (1) | EP4426314A4 (enExample) |
| JP (1) | JP2024540303A (enExample) |
| KR (1) | KR20240112283A (enExample) |
| CN (1) | CN118401245A (enExample) |
| AU (1) | AU2022381187A1 (enExample) |
| CA (1) | CA3236861A1 (enExample) |
| CL (1) | CL2024001364A1 (enExample) |
| IL (1) | IL312466A (enExample) |
| MX (1) | MX2024005429A (enExample) |
| PE (1) | PE20250676A1 (enExample) |
| TW (1) | TW202334136A (enExample) |
| WO (1) | WO2023081757A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL297625B2 (en) | 2020-04-29 | 2026-05-01 | Relay Therapeutics Inc | PI3K-alpha inhibitors and methods of using them |
| WO2024055992A1 (zh) * | 2022-09-14 | 2024-03-21 | 南京再明医药有限公司 | 三环化合物及其应用 |
| WO2024097721A1 (en) | 2022-11-02 | 2024-05-10 | Petra Pharma Corporation | Targeting allosteric and orthosteric pockets of phosphoinositide 3-kinase (pi3k) for the treatment of disease |
| KR20260005985A (ko) | 2023-05-05 | 2026-01-12 | 일라이 릴리 앤드 캄파니 | Er+ 유방암을 갖는 대상체에서 중추 신경계 (cns) 전이를 치료 및 예방하는 데 사용하기 위한 임루네스트란트 또는 그의 염 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2010007100A1 (en) * | 2008-07-15 | 2010-01-21 | Cellzome Ltd | 7-substituted amino triazoles as pi3k inhibitors |
| MA38884A1 (fr) * | 2013-09-05 | 2017-06-30 | Hoffmann La Roche | Composé de triazolopyridine, compositions et procédés d'utilisation associés |
| WO2017000277A1 (en) * | 2015-07-01 | 2017-01-05 | Merck Sharp & Dohme Corp. | Substituted triazolo bicycliccompounds as pde2 inhibitors |
| JP7426398B2 (ja) * | 2019-02-26 | 2024-02-01 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | Ｒａｓ阻害剤としての新規イソインドリノン置換インドールおよび誘導体 |
| IL297625B2 (en) * | 2020-04-29 | 2026-05-01 | Relay Therapeutics Inc | PI3K-alpha inhibitors and methods of using them |
-
2022
- 2022-11-02 TW TW111141786A patent/TW202334136A/zh unknown
- 2022-11-03 CA CA3236861A patent/CA3236861A1/en active Pending
- 2022-11-03 CN CN202280082873.4A patent/CN118401245A/zh active Pending
- 2022-11-03 WO PCT/US2022/079221 patent/WO2023081757A1/en not_active Ceased
- 2022-11-03 US US18/706,511 patent/US20260125374A1/en active Pending
- 2022-11-03 IL IL312466A patent/IL312466A/en unknown
- 2022-11-03 PE PE2024001004A patent/PE20250676A1/es unknown
- 2022-11-03 JP JP2024526614A patent/JP2024540303A/ja active Pending
- 2022-11-03 MX MX2024005429A patent/MX2024005429A/es unknown
- 2022-11-03 AU AU2022381187A patent/AU2022381187A1/en active Pending
- 2022-11-03 KR KR1020247018494A patent/KR20240112283A/ko active Pending
- 2022-11-03 EP EP22891040.2A patent/EP4426314A4/en active Pending
-
2024
- 2024-05-03 CL CL2024001364A patent/CL2024001364A1/es unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2731179C2 (ru) | Фенфлураминовые композиции и способы их получения | |
| RU2213743C2 (ru) | Производное тиенилазолилалкоксиэтанамина, способ его получения (варианты), фармацевтическая композиция, промежуточный продукт и способ его получения (варианты) | |
| FR2823209A1 (fr) | Nouvelles thiohydantoines et leur utilisation en therapeutique | |
| JPH08501095A (ja) | 置換チアゾリジンジオン誘導体 | |
| MXPA03011448A (es) | Derivados de n-arilfenilacetamida y composicion farmaceutica que los contienen. | |
| JP2001523712A (ja) | Ｐｄｅ−ｉｖのベンゼンスルホンアミド阻害剤およびそれらの治療的使用 | |
| JP2010540638A (ja) | セラミド誘導体を用いる多発性嚢胞腎疾患の治療方法 | |
| US7879886B2 (en) | Iron binding agents | |
| JP5179190B2 (ja) | 神経変性疾病の治療において１，４−ビス（３−アミノアルキル）ピペラジン誘導体を使用する方法 | |
| HU179170B (en) | Process for producing phenethanolamine derivatives | |
| JP5833143B2 (ja) | フェニル−イソオキサゾール誘導体およびその製造方法 | |
| KR20200131382A (ko) | 펠루비프로펜의 신규 염, 이의 제조방법 및 이를 포함하는 약학적 조성물 | |
| JP2005529933A (ja) | キサンチンホスホジエステラーゼｖインヒビター多形体 | |
| CN111954663A (zh) | 氟化的4-(取代的氨基)苯基氨基甲酸酯衍生物 | |
| US11571416B2 (en) | Amodiaquine analogs and methods of uses thereof | |
| CN1642926A (zh) | 结晶帕瑞考昔钠 | |
| TW200418792A (en) | Amino acid phenoxy ethers | |
| US20110269838A1 (en) | Novel processes and pure polymorphs | |
| US20110224269A1 (en) | Analgesic Compounds, Compositions, and Uses Thereof | |
| JP3891503B2 (ja) | 製薬学的に活性なβ−アミノ酸類の許容性の改善 | |
| JP2017514841A (ja) | 多形形態の［５−フルオロ−３−（｛２−［（４−フルオロベンゼン）スルホニル］ピリジン−３−イル｝メチル）−２−メチルインドール−１−イル］−酢酸 | |
| CN1295229C (zh) | 紫杉烷衍生物的结晶及其制备方法 | |
| KR20090093807A (ko) | 신경보호효과를 가지는 피루베이트 유도체, 이의 제조방법 및 이를 포함하는 약제학적 조성물 | |
| JPS6326101B2 (enExample) | ||
| US8754129B2 (en) | Crystalline vorinostat form VI |